Skip to main content

Advertisement

SpringerLink
Log in

Placental site trophoblastic tumor with multiple metastases and complete response to salvage BEP regimen: a case report and review of the literature

  • CASE
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Placental site trophoblastic tumor is a rare form of gestational trophoblastic disease, derived from invasive implantation site (intermediate) trophoblastic cells. It is frequently resistant to chemotherapy. Patients with metastases, however, frequently have progressive disease and die despite surgery and multiagent chemotherapy. In this case, a 24-year-old woman was referred because of intermittent vaginal bleeding episodes for 5 months following delivery. Multiple metastases in lungs, liver, kidneys, breast, pancreas, and adrenal and thyroid glands were detected. Combination therapy including surgery and multiagent chemotherapy was planned. Hysterectomy and pelvic lymph node dissection were performed. All metastatic lesions disappeared with EMA-CO treatment. However four courses of BEP regimen, salvage therapy, was performed for plateauing hCG level. Surgery and multiagent chemotherapy seem mainstay of treatment of cases having multiple metastases of PSTTs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Chang YL, Chang TC, Hsueh S, Huang KG, Wang PN, Liu HP, Soong YK. Prognostic factors and treatment for placental site trophoblastic tumor-report of 3 cases and analysis of 88 cases. Gynecol Oncol. 1999;73(2):216–22. doi:10.1006/gyno.1999.5344.

    Article  PubMed  CAS  Google Scholar 

  2. Seckl MJ, Newland ES. Management of gestational trophoblastic disease. In: Gershenson DM, McGuire WP, Gore M, Quinn MA, Thomas G, editors. Gynecologic cancer: controversies in management. Philadelphia: Churchill Livingstone/Elsevier Ltd.; 2004, p. 555–573.

  3. Newlands ES, Mulholland PJ, Holden L, Seckl MJ, Rustin GJ. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol. 2000;18(4):854–9.

    PubMed  CAS  Google Scholar 

  4. Hartenbach EM, Saltzman AK, Carter JR, Twiggs LB. A novel strategy using G-CSF to support EMA/CO for high-risk gestational trophoblastic disease. Gynecol Oncol. 1995;56(1):105–8. doi:10.1006/gyno.1995.1019.

    Article  PubMed  CAS  Google Scholar 

  5. Piura B, Rabinovich A, Meirovitz M, Shaco-Levy R. Placental site trophoblastic tumor: report of four cases and review of literature. Int J Gynecol Cancer. 2007;17(1):258–62. doi:10.1111/j.1525-1438.2006.00774.x.

    Article  PubMed  CAS  Google Scholar 

  6. Baergen RN, Rutgers JL, Young RH, Osann K, Scully RE. Placental site trophoblastic tumor: a study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol. 2006;100(3):511–20. doi:10.1016/j.ygyno.2005.08.058.

    Article  PubMed  Google Scholar 

  7. Hassadia A, Gillespie A, Tidy J, Everard RGNJ, Wells M, Coleman R, Hancock B. Placental site trophoblastic tumour: clinical features and management. Gynecol Oncol. 2005;99(3):603–7. doi:10.1016/j.ygyno.2005.06.054.

    Article  PubMed  Google Scholar 

  8. Creasman WT. Revision in classification by International federation of gynecology and obstetrics, letter to the editor Am J Obstet Gynecol. 1992;167:857–8.

    PubMed  CAS  Google Scholar 

  9. Seung JK. Placental site trophoblastic tumour. Best Pract Res Clin Obstet Gynaecol. 2003;17(6):969–84. doi:10.1016/S1521-6934(03)00095-6.

    Article  Google Scholar 

  10. Papadopoulos AJ, Foskett M, Seckl MJ, McNeish I, Paradinas FJ, Rees H, Newlands ES. Twenty-five years’ clinical experience with placental site trophoblastic tumors. J Reprod Med. 2002;47(6):460–4.

    PubMed  Google Scholar 

  11. Nagai Y, Kamoi S, Matsuoka T, Hata A, Jobo T, Ogasawara T, Aoki Y, Ohira S, Okamoto T, Nakamoto T, Kanda K, Matsui H. Impact of p53 immunostaining in predicting advanced or recurrent placental site trophoblastic tumors: a study of 12 cases. Gynecol Oncol. 2007;106(3):446–52.

    Google Scholar 

  12. Paradinas FJ, Elston CW. Gestational trophoblastic diseases. In: Fox H, Wells M, editors. Obstetrical and gynaecological pathology. 5th ed. London: Churchill Livingstone; 2003. p. 1359–1430.

    Google Scholar 

  13. Raza A, Ahmad Z, Muzzaffar S. Placental site trophoblastic tumor (PSTT) with metastases to lungs and adrenal glands. J Coll Physicians Surg Pak. 2006;16(2):150–1.

    PubMed  Google Scholar 

  14. Bruni R, Nigita G, Pagani Guazzugli Bonaiuti V, Petrocca S, Terenzi A. Adrenal metastatic placental site trophoblastic tumor. Case report. Chir Ital. 2003;55(2):257–60.

    PubMed  Google Scholar 

  15. Li BZ, Zhu L, Duan W. Clinicopathologic study of tumors of intermediate trophoblasts. Zhonghua Bing Li Xue Za Zhi. 2006;35(12):722–6.

    PubMed  Google Scholar 

  16. Dainty LA, Winter WE 3rd, Maxwell GL. The clinical behavior of placental site trophoblastic tumor and contemporary methods of management. Clin Obstet Gynecol. 2003;46(3):607–11. doi:10.1097/00003081-200309000-00011.

    Article  PubMed  Google Scholar 

  17. Monclair T, Abeler VM, Kaern J, Walaas L, Zeller B, Hilstrom C. Placental site trophoblastic tumor (PSTT) in mother and child: first report of PSTT in infancy. Med Pediatr Oncol. 2002;38:187–91. doi:10.1002/mpo.1308.

    Article  PubMed  Google Scholar 

  18. Singer G, Kurman RJ, McMaster MT, Shih IeM. HLA-g immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as useful marker in differential diagnosis. Am J Surg Pathol. 2002;26(7):914–20. doi:10.1097/00000478-200207000-00010.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gynecology and Obstetrics, Zeynep Kamil Maternity and Child Research and Training Hospital, Istanbul, Turkey

    Selcuk Ayas, Ayse Gurbuz & Ates Karateke

  2. Department of Pathology, Zeynep Kamil Maternity and Child Research and Training Hospital, Istanbul, Turkey

    Handan Cetiner

Authors
  1. Selcuk Ayas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ayse Gurbuz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ates Karateke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Handan Cetiner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Selcuk Ayas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ayas, S., Gurbuz, A., Karateke, A. et al. Placental site trophoblastic tumor with multiple metastases and complete response to salvage BEP regimen: a case report and review of the literature. Med Oncol 26, 96–100 (2009). https://doi.org/10.1007/s12032-008-9076-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-008-9076-9

Keywords

Search

Navigation